Literature DB >> 12214008

Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.

Dannie Etiene1, Joanny Kraft, Neema Ganju, Teresa Gomez-Isla, Brad Gemelli, Bradley T. Hyman, E. Tessa Hedley-Whyte, Jack R. Wands, Suzanne M. De La Monte.   

Abstract

Heterogeneous pathology in Alzheimer's Disease (AD) is due to variability in the nature and severity of lesions, overlap with other neurodegenerative diseases such as Parkinson's disease, or the co-existence of cerebrovascular disease. In the MGH-ADRC autopsy archives, remote cerebral infarcts (CVA) were reported in 30% of the otherwise uncomplicated AD cases. To determine the potential significance of cerebrovascular lesions in relation to AD, the relative densities (CERAD grading criteria) of Bielschowsky-stained AD lesions and Ab-amyloid immunoreactive plaques were compared among cases of AD+CVA (N=52), AD (N=48), aged controls (NC; N=9), and aged controls with AD lesions (ADC; N=8). The prevalence of the ApoE varepsilon 4 allele was also determined for each group. This study demonstrated: 1) higher densities of Bielschowsky-stained plaques in AD, AD+CVA, and ADC than in NC (P<0.0001); 2) more abundant neurofibrillary tangles in AD relative to all other groups (P<0.0005), and in AD+CVA and ADC relative to NC (P<0.05); and 3) increased densities of Ab-amyloid-immunoreactive plaques in AD relative to AD+CVA (P=0.0003). In AD+CVA, cerebral vascular lesions consisting of remote microscopic cortical and subcortical white matter infarcts, ischemic lesions, and leukoaraiosis were consistently distributed in structures typically damaged by AD neurodegeneration, as well as in the basal ganglia. The ApoE varepsilon 4 allele was more prevalent in the AD+CVA (70%) than in the AD (58%) group (P=0.05). Since the AD and AD+CVA groups had similar degrees of dementia, the results suggest that cerebral vascular lesions in regions typically destroyed by AD may contribute to the clinical manifestations of AD.

Entities:  

Year:  1998        PMID: 12214008     DOI: 10.3233/jad-1998-1205

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Fabrizio Vecchio; Roberta Lizio; Michela Pievani; Geroldi Cristina; Claudia Fracassi; Fabrizio Vernieri; Guido Rodriguez; Flavio Nobili; Raffaele Ferri; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2010-12-22       Impact factor: 5.038

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

Review 3.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

4.  Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease.

Authors:  Daniel A Nation; Lisa Delano-Wood; Katherine J Bangen; Christina E Wierenga; Amy J Jak; Lawrence A Hansen; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 6.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

7.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.

Authors:  F-E De Leeuw; F Barkhof; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 9.  Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Authors:  Gjumrakch Aliev; Mark A Smith; Mark E Obrenovich; Jack C de la Torre; George Perry
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.